To help narrow down the options, we've compiled a review of the most trusted lower limb rehabilitation exoskeletons used in neurology departments worldwide. Each model was evaluated based on the features above, as well as real-world feedback from therapists and patients.
|
Model
|
Manufacturer
|
Key Features
|
Best For
|
Safety Certifications
|
Approximate Price Range
|
|
EksoNR
|
Ekso Bionics
|
Adjustable step length, real-time gait correction, wireless data sync, supports partial to full weight-bearing
|
Stroke, SCI, TBI, neurodegenerative diseases
|
FDA-cleared, CE-marked
|
$75,000 – $95,000
|
|
HAL (Hybrid Assistive Limb)
|
CYBERDYNE
|
Myoelectric sensors detect muscle signals, adapts to user's intended movement, lightweight carbon fiber frame
|
Stroke, SCI, muscular dystrophy
|
FDA-cleared (for rehabilitation), CE-marked
|
$100,000 – $120,000
|
|
ReWalk ReStore
|
ReWalk Robotics
|
Portable design, battery-powered, supports home use after clinic training, app-based control
|
Mild to moderate stroke, incomplete SCI
|
FDA-cleared, CE-marked
|
$50,000 – $70,000
|
|
Ossur ExoSym
|
Ossur
|
Low-profile, passive assistance (no motors), ideal for patients with residual strength, lightweight (3.5 lbs per leg)
|
Mild hemiparesis, foot drop, post-stroke recovery
|
FDA-cleared, CE-marked
|
$5,000 – $8,000
|
Deep Dive: EksoNR by Ekso Bionics
Widely regarded as a gold standard in neurology departments, the EksoNR stands out for its versatility and focus on neurorehabilitation. Its adjustable frame fits patients from 5'0" to 6'4" and supports weights up to 300 lbs, making it suitable for most adults. What truly sets it apart, though, is its "Adaptive Gait" technology—sensors track the patient's movement in real time, and the exoskeleton adjusts its assistance to match their effort. For example, if a stroke patient struggles to lift their affected leg, the EksoNR provides extra power to clear the foot, then reduces assistance as they gain strength.
Therapists praise its user-friendly interface, which allows them to tweak settings (like step height or speed) mid-session without interrupting the patient. The built-in data dashboard logs metrics like step count, symmetry, and weight distribution, making it easy to track progress over weeks or months. One downside? Its size and weight (around 50 lbs) require a stable base, so it's best suited for clinic use rather than home settings.
Deep Dive: HAL by CYBERDYNE
For patients with some residual muscle function, the HAL exoskeleton offers a unique approach: it uses myoelectric sensors attached to the skin to detect faint electrical signals from the patient's muscles. When the patient thinks about moving their leg, the sensors pick up the signal, and the exoskeleton's motors kick in to assist. This "intent-based" control is particularly effective for reactivating neural pathways, as it encourages the patient to actively participate in movement rather than passively being moved.
HAL is also one of the lighter options on the market, thanks to its carbon fiber construction, which reduces fatigue for both patients and therapists. However, its reliance on muscle signals means it may not work as well for patients with severe muscle atrophy or nerve damage. It's also one of the pricier models, which can be a barrier for smaller departments.